Sorafenib (BAY-43-9006)

DRUG2 trials

Sponsors

Istituto Clinico Humanitas

Conditions

Carcinoma, HepatocellularSarcoma, Soft Tissue

Phase 2

BAY-43-9006 in Advanced, Metastatic Soft Tissue Sarcomas

CompletedNCT00406601

Istituto Clinico HumanitasSarcoma, Soft Tissue

Start: 2006-11-30End: 2010-09-30Updated: 2010-09-02

Dose Escalation of Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)

CompletedNCT00490685

Istituto Clinico HumanitasCarcinoma, Hepatocellular

Start: 2007-04-30Updated: 2010-09-02